Bionano Genomics
Bionano Genomics' Chinese Partner Nabs NMPA Approval for Saphyr OGM Platform
With the approval, Bionano's OEM partner Hangzhou Diagens Biotechnology can now sell the platform directly to hospitals and clinical labs in China.
In Brief This Week: Myriad Genetics, Thermo Fisher Scientific, DeepUll, Roche, Immunovia, More
News items for the weeks of Nov. 25 and Dec. 2, 2024.
In Brief This Week: Siemens Healthineers, DiaCarta, Bionano Genomics, PathAI
News items for the week of Sept. 30, 2024.
Bionano Genomics Upbeat on Further Clinical Adoption of Optical Genome Mapping With New CPT Code
Premium
The Category I CPT code paves the way for reimbursement of OGM-based clinical tests, though details on pricing and insurance coverage are still unclear.
Bionano Genomics Inks OEM Deal With Chinese Partner to Commercialize Clinical Cytogenetics Workflow
Hangzhou Diagens Biotechnology has received China NMPA approval for Bionano's reagents and plans to register the Saphyr instrument for use in reproductive health.